Dendritic Cell Vaccination is Effective Against H3.3G34R Mutant Glioblastoma in a Novel Syngeneic Genetically Engineered Mouse Model

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy